A therapeutic RANKL vaccine induces neutralizing anti-RANKL antibodies and prevents bone loss in ovariectomized mice.

被引：0
|
作者：
Hertz, M
Juji, T
Tanaka, S
Mouritsen, S
机构：
[1] Univ Tokyo, Dept Orthopaed Surg, Tokyo, Japan
[2] M&E Biotech AS, Horsholm, Denmark
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2001年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S222 / S222
页数：1
相关论文
共 50 条
  • [31] Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis (vol 31, pg 4855, 2017)
    Chen, X.
    Zhi, X.
    Pan, P.
    Cui, J.
    Cao, L.
    Weng, W.
    Zhou, Q.
    Wang, L.
    Zhai, X.
    Zhao, Q.
    Hu, H.
    Huang, B.
    Su, J.
    FASEB JOURNAL, 2020, 34 (11): : 15621 - 15622
  • [32] Effects of single or combination therapy of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in mice
    Kitaguchi, Kazuma
    Kashii, Masafumi
    Ebina, Kosuke
    Kaito, Takashi
    Okada, Rintaro
    Makino, Takahiro
    Noguchi, Takaaki
    Ishimoto, Takuya
    Nakano, Takayoshi
    Yoshikawa, Hideki
    BONE, 2018, 106 : 1 - 10
  • [33] A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders
    Takuo Juji
    Marc Hertz
    Kazuhiro Aoki
    Daisuke Horie
    Keiichi Ohya
    Anand Gautam
    Søren Mouritsen
    Hiromi Oda
    Kozo Nakamura
    Sakae Tanaka
    Journal of Bone and Mineral Metabolism, 2002, 20 : 266 - 268
  • [34] A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders
    Juji, T
    Hertz, M
    Aoki, K
    Horie, D
    Ohya, K
    Gautam, A
    Mouritsen, S
    Oda, H
    Nakamura, K
    Tanaka, S
    JOURNAL OF BONE AND MINERAL METABOLISM, 2002, 20 (05) : 266 - 268
  • [35] PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
    Choi, Joo-Hee
    Jang, Ah-Ra
    Kim, Dong-il
    Park, Min-Jung
    Lim, Seul-Ki
    Kim, Myung-Sun
    Park, Jong-Hwan
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2018, 50 : 1 - 15
  • [36] Tart Cherry Prevents Bone Loss through Inhibition of RANKL in TNF-Overexpressing Mice
    Moon, Nicholas
    Effiong, Linda
    Song, Lee
    Gardner, Thomas R.
    Soung, Do Y.
    NUTRIENTS, 2019, 11 (01)
  • [37] Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis
    Li, Chang-hong
    Lu, Zi-rui
    Zhao, Zhen-da
    Wang, Xin-yu
    Leng, Hui-jie
    Niu, Yan
    Wang, Mo-pei
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
    Joo-Hee Choi
    Ah-Ra Jang
    Dong-il Kim
    Min-Jung Park
    Seul-Ki Lim
    Myung-Sun Kim
    Jong-Hwan Park
    Experimental & Molecular Medicine, 2018, 50 : 1 - 15
  • [39] Combined effect of teriparatide and an anti-RANKL monoclonal antibody on bone defect regeneration in mice with glucocorticoid-induced osteoporosis
    Etani, Yuki
    Ebina, Kosuke
    Hirao, Makoto
    Kitaguchi, Kazuma
    Kashii, Masafumi
    Ishimoto, Takuya
    Nakano, Takayoshi
    Okamura, Gensuke
    Miyama, Akira
    Takami, Kenji
    Goshima, Atsushi
    Kanamoto, Takashi
    Nakata, Ken
    Yoshikawa, Hideki
    BONE, 2020, 139
  • [40] Evodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice
    Jin, Haiming
    Yao, Lingya
    Chen, Kai
    Liu, Yuhao
    Wang, Qingqing
    Wang, Ziyi
    Liu, Qian
    Cao, Zhen
    Kenny, Jacob
    Tickner, Jennifer
    Wang, Xiangyang
    Xu, Jiake
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (01) : 522 - 534
12345